ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $199,000 | +32.7% | 8,164 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $150,000 | +21.0% | 8,125 | +8.1% | 0.00% | – |
| Q2 2017 | $124,000 | +93.8% | 7,518 | +61.5% | 0.00% | – |
| Q1 2017 | $64,000 | -22.0% | 4,654 | +8.0% | 0.00% | – |
| Q4 2016 | $82,000 | -99.9% | 4,309 | -0.3% | 0.00% | – |
| Q3 2016 | $95,840,000 | +21.6% | 4,321 | +0.1% | 0.00% | – |
| Q2 2016 | $78,835,000 | +35.9% | 4,315 | +36.4% | 0.00% | – |
| Q1 2016 | $58,000,000 | +9.4% | 3,163 | 0.0% | 0.00% | – |
| Q4 2015 | $53,000,000 | +92882.5% | 3,163 | -0.2% | 0.00% | – |
| Q3 2015 | $57,000 | -99.9% | 3,169 | +0.1% | 0.00% | – |
| Q2 2015 | $81,904,000 | -6.5% | 3,166 | -20.8% | 0.00% | – |
| Q1 2015 | $87,600,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |